RT Journal Article
SR Electronic
T1 Characterization of CSF inflammatory markers after hemorrhagic stroke and their relationship to disease severity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.05.23299566
DO 10.1101/2023.12.05.23299566
A1 Magid-Bernstein, Jessica
A1 Yan, Jennifer
A1 Herman, Alison L.
A1 He, Zili
A1 Johnson, Conor W.
A1 Beatty, Hannah
A1 Choi, Rachel
A1 Velazquez, Sofia
A1 Neeman, Eitan
A1 Falcone, Guido
A1 Kim, Jennifer
A1 Petersen, Nils
A1 Gilmore, Emily J.
A1 Matouk, Charles
A1 Sheth, Kevin
A1 Sansing, Lauren
YR 2023
UL http://medrxiv.org/content/early/2023/12/07/2023.12.05.23299566.abstract
AB Background The inflammatory response within the central nervous system is a key driver of secondary brain injury after hemorrhagic stroke, both in patients with intracerebral hemorrhage (ICH) and aneurysmal subarachnoid hemorrhage (aSAH). In this study, we aimed to characterize inflammatory molecules in the blood and cerebrospinal fluid (CSF) of patients within 72 hours of hemorrhage to understand how such molecules vary across disease types and disease severity.Methods Biological samples were collected from patients admitted to a single-center Neurosciences Intensive Care Unit with a diagnosis of ICH or aSAH between 2014 and 2022. Control CSF samples were collected from patients undergoing CSF diversion for normal pressure hydrocephalus. A panel of immune molecules in the plasma and CSF samples was analyzed using Cytometric Bead Array assays. Clinical variables, including demographics, disease severity, and intensive care unit length of stay were collected.Results Plasma and/or CSF samples were collected from 260 patients (188 ICH patients, 54 aSAH patients, 18 controls). C-C motif chemokine ligand-2 (CCL2), interleukin-6 (IL-6), granulocyte-colony stimulating factor (G-CSF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF), were detectable in the CSF within the first 3 days after hemorrhage, and all were elevated compared to plasma. Compared with controls, CCL2, IL-6, IL-8, G-CSF, and VEGF were elevated in the CSF of both ICH and aSAH patients (p<0.01 for all comparisons). VEGF was increased in ICH patients compared to aSAH patients (p<0.01). CCL2, G-CSF, and VEGF in the CSF were associated with more severe disease in aSAH patients only.Conclusions Within 3 days of hemorrhagic stroke, proinflammatory molecules can be detected in the CSF at higher concentrations than in the plasma. Early concentrations of some pro-inflammatory molecules may be associated with markers of disease severity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Sansing received support related to this work from NIH/NINDS (R01NS097728). Dr. Magid-Bernstein received support related to this work from the Neurocritical Care Society (AWD0007451) and the American Heart Association (23CDA1054469).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Yale School of Medicine IRB, and consent was obtained from patients or their legally authorized representative.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesA deidentified version of the data is available upon request.ICHintracerebral hemorrhageaSAHaneurysmal subarachnoid hemorrhageDCIdelayed cerebral ischemiaCSFcerebrospinal fluidEVDexternal ventricular drainCCL2C-C motif chemokine ligand-2IL-6interleukin-6G-CSFgranulocyte-colony stimulating factorIL-8interleukin-8VEGFvascular endothelial growth factorCNScentral nervous systemNPHnormal pressure hydrocephalusIL-1βinterleukin-1 betaIL-4interleukin-4MIP-1αmacrophage inflammatory protein-1 alphaIL-10interleukin-10TNF-αtumor necrosis factor alphaIL-17interleukin-17ICUIntensive Care UnitGCSGlasgow Coma ScaleIQRinterquartile rangeANOVAanalysis of variance